BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17915824)

  • 1. Sintering of wax for controlling release from pellets.
    Singh R; Poddar SS; Chivate A
    AAPS PharmSciTech; 2007 Sep; 8(3):E74. PubMed ID: 17915824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
    Maboos M; Yousuf RI; Shoaib MH; Nasiri I; Hussain T; Ahmed HF; Iffat W
    Lipids Health Dis; 2018 Jun; 17(1):136. PubMed ID: 29885655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.
    Qazi F; Shoaib MH; Yousuf RI; Nasiri MI; Ahmed K; Ahmad M
    Lipids Health Dis; 2017 Apr; 16(1):75. PubMed ID: 28403892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms.
    Cheboyina S; Wyandt CM
    Int J Pharm; 2008 Jul; 359(1-2):167-73. PubMed ID: 18495391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique I. Formulation and process variables affecting pellet characteristics.
    Cheboyina S; Wyandt CM
    Int J Pharm; 2008 Jul; 359(1-2):158-66. PubMed ID: 18499369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary evaluation of an aqueous wax emulsion for controlled-release coating.
    Walia PS; Stout PJ; Turton R
    Pharm Dev Technol; 1998 Feb; 3(1):103-13. PubMed ID: 9532605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.
    Tian L; Zhang Y; Tang X
    Drug Dev Ind Pharm; 2008 Jun; 34(6):569-76. PubMed ID: 18568906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained release pellets based on poly(N-isopropyl acrylamide): matrix and in situ photopolymerization-coated systems.
    Mayo-Pedrosa M; Alvarez-Lorenzo C; Lacík I; Martinez-Pacheco R; Concheiro A
    J Pharm Sci; 2007 Jan; 96(1):93-105. PubMed ID: 16967440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro release of theophylline from poly(lactic acid) sustained-release pellets prepared by direct compression.
    Kader A; Jalil R
    Drug Dev Ind Pharm; 1998 Jun; 24(6):527-34. PubMed ID: 9876618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of spherical pellets by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    Int J Pharm; 2002 Aug; 242(1-2):87-92. PubMed ID: 12176229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Quality evaluation of sustained release pellets of eperisone HCl.
    Jawed SH; Muhammad IN; Qazi F; Shoaib MH; Arshad HM; Siddiqui T
    Pak J Pharm Sci; 2021 Jan; 34(1(Supplementary)):225-235. PubMed ID: 34275846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-unit dosage formulations of theophylline for controlled release applications.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(6):553-9. PubMed ID: 18323251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast and controlled release of triamcinolone acetonide from extrusion-spheronization pellets based on mixtures of native starch with dextrin or waxy maize starch.
    Sergio AP; Isabel de SF; José BM; Otero-Espinar FJ
    Drug Dev Ind Pharm; 2007 Sep; 33(9):945-51. PubMed ID: 17891580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained release from inert wax matrixes I: drug-wax combinations.
    Schroeder HG; Dakkuri A; DeLuca PP
    J Pharm Sci; 1978 Mar; 67(3):350-3. PubMed ID: 641721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melt granulation and heat treatment for wax matrix-controlled drug release.
    Zhang YE; Schwartz JB
    Drug Dev Ind Pharm; 2003 Feb; 29(2):131-8. PubMed ID: 12648009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomimetic Modification of Water-Borne Polymer Coating with Carnauba Wax for Controlled Release of Urea.
    Ge C; Xu X; Ma F; Zhou J; Du C
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. I. Oil-in-water technique for water-insoluble drugs.
    Bodmeier R; Wang J; Bhagwatwar H
    J Microencapsul; 1992; 9(1):89-98. PubMed ID: 1613647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnauba wax as a promising excipient in melt granulation targeting the preparation of mini-tablets for sustained release of highly soluble drugs.
    Nart V; Beringhs AO; França MT; de Espíndola B; Pezzini BR; Stulzer HK
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):250-257. PubMed ID: 27770888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melt extruded helical waxy matrices as a new sustained drug delivery system.
    Hasa D; Perissutti B; Grassi M; Zacchigna M; Pagotto M; Lenaz D; Kleinebudde P; Voinovich D
    Eur J Pharm Biopharm; 2011 Nov; 79(3):592-600. PubMed ID: 21827851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.